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1074-99 Physician-Prescribing Patterns Among Patients 
Undergoing Coronary Artery Bypass Graft Surgery: 
Results From the ROSETTA-CABG Registry 
Karen OkraineC Mark J. Eisenberg, Louise Pilote. Jewish General Hospital, Montreal, 
PQ, Canada 
Background: GuIdeline statements have provided recommendations on appropriate 
medical therapy for patients with CAD and specific co-morbid conditions. Little is known 
on whether these recommendations are being followed in clinical practice in patients 
undergoing coronary artery bypass graft (CABG) surgery. Methods: We examined the 
rates of medical therapy among 255 patients who were enrolled in the Routine versus 
Selective Exercise Treadmill Testing After CABG (ROSETTA-CABG) Study, a prospec- 
tive multicenter study examining the use of functional testing after CABG at 12 clinical 
centers in 4 countries. Results: At discharge and 12.months. rates of aspirin were 92% 
and 66%. Anti-lipid treatment was low at discharge (56%) but increased by 12.months 
(78%). eblocker use was high at discharge (72%) but decreased by 12.months (65%). 
Rates of calcium antagonist use were low at both discharge and 12.months (19%,19%). 
Rates of ACE inhibitors remained stable from discharge to 12.months (30% to 38%). 
Rates of these medications among subgroups can be found in Table 1. Conclusion: 
Although physicians appear to be followng guidelInes regarding aspirin use, antl-lipid 
agents and ACE Inhibitors are under prescribed among patients known to benefit from 
them. Moreover, anti-lschemic medications are over prescribed among patients with no 
recurrent ischemia or Indication for their use. 
Endpoint 
30.Day Death 
30.Day Ml 
30.Day Death/Ml 
6.Month Death 
6-Month Ml 
6-Month Death/Ml 
Placebo 
N=l332 
5.1% 
23.3% 
26.0% 
7.0% 
27.4% 
31.2% 
GP Ilb/llla 
N=l634 
5.1% 
19.7% 
22.6% 
7.1% 
23.7% 
27.0% 
P 
0.965 
0.017 
0.035 
0.915 
0.037 
0.023 
1074-97 Troponin T Elevation Following Cardiac Surgery Is 
Associated With Increased One-Year Mortality and 
Morbidity 
Sekar Kathiresar! John B. Newell, Stephen J. Servoss, Dawn Trani, Thomas E. 
MacGillivray. Kent Lewandrowski, Elizabeth L. Lewandrowski, James L. Januui, Jr., 
Massachusetts General Hospital, Boston, MA 
Background: Serum Troponin T (TnT) elevation after cardiac surgery predicts impend- 
Ing in-hospital complications. Whether cardiac TnT predicts medium-term outcomes after 
cardiac surgery remains undefined. Methods: In a prognostic study of 224 patients 
undergoing cardiac surgery, serial blood sampling of TnT was performed at three time 
intewals: immediate postoperative, 6-12 hours. and 16-24 hours. One-war follow-w for 
adverse events including recurrent ischemia (RI), congestive heart f&we (CHF) and 
death was obtained in 97.3% of the oatients. TnT levels were loo-transformed. and 
divided into quintiles for analysis. Clinical variables including baseline demographics, as 
well es both creatine kinase MB isoenzyme (CK-MB) and TnT levels, were assessed with 
Cox-proportional hazards modeling to identity independent predictors of one-year out- 
comes. Results: A TnT level in the highest log quintile (~I.56 nglml) following cardiac 
surgery was the strongest predictor of cardiac complications at one-year, identifying 
patients at high risk for RI, CHF, and mortality, as well as composites of these endpoints 
(see Table 1). In the presence of TnT, the results of CK-MB testing added no significant 
independent prognostic information. Conclusions: Assessment of TnT after cardiac SUF 
gery may identify patients with a considerably increased risk for morbidity and mortality 
during the first year after heart surgery. 
Risk For One Year Adverse Outcomes Per Log QuintlIe TnT 
Endpoint Odds Ratio 95% Cl P value 
CHF (1x12) 33.0 6.2-130.0 <0.00005 
RI (n=l6) 3.3 1.2-9.1 0.012 
Death (n=15) 39.0 13.2-114.0 co.oooo5 
CHFlAl (n=26) 6.6 2.3-16.5 0.0004 
Death/RI (n=26) 6.4 2.4-17.5 0.0003 
DeathlRIICHF (n=34) 5.6 2.3-13.7 0.0001 
1074-98 Influence of Depression on Disease Specific Functional 
Status Recovery Following Coronary Bypass Surgery 
Mukesh Garq, Carlos Poston, John A. Spertus, Mid America Heart Institute. St. Luke’s 
Hospital, Kansas City, MO, Truman Medical Center, University of Missouri Kansas City 
School of Medicine, Kansas City, MO 
Background: Depression is known to mfluence cllnical outcome in patients with CAD. 
Little information is available on role of depression in recovery of disease specific func- 
ttonal status after CABG. Methods: This study prospectively tracked 224 patients’ func- 
tlonal status at baseline and at monthly intervals for 6 months following CABG. The 
Seattle Angina Questionnaire (SAQ) was used to assess angina frequency (AF), physical 
limitation (PL) due to angina, and disease specific quality of life (QOL). SAQ scores 
range O-100 where higher scores indicate better functioning. Baseline depression was 
assessed using the Mental Health Indexd. Results: 
Basehne variables (Age, gender distribution, EF, prior MI, prior revascularization, smok- 
ing, COPD. HTN. CHF. education, marital status, % living alone, and household income) 
were similar in the two groups. Depressed patients (n = 14) were more likely to have 
renal insufficiency (20% vs. 6%; p= .02), stroke (27% vs. 6%; p= .04). DM (53% vs. 27%; 
p= .04) and reported more economical strain (73% vs. 44% (p= ,001). Prior to CABG, 
depressed patients had more frequent angina (mean SAC? score 51+ 26 vs. 67 * 26 for 
non-depressed; p= .03) and were more physically limited compared to non-depressed 
patients (mean SAQ score 46 * 29 vs 66 + 25; p= ,006). Six months after CABG 
depressed patients had substantial improvement in angina frequency and physical limita- 
tion from angina, to a level comparable to non-depressed patients (mean SAQ AF score 
93 f 14 “s 93 * 12; p= .96, and mean SAQ PL score = 72 * 23 “s 76 * 22; p= .54). QOL 
was similar in both groups at baseline (mean SAQ score= 47 * 29 for depressed and 54 
+ 22 for non-depressed; p= .39). and improved similarly in both depressed and non- 
depressed patients (6 months mean SAQ score 64 t 16 vs. 84 * 17; p= .69). Conclu- 
sion: Although at presentation for CABG, depressed patients have more frequent angina 
and are more physically limited compared to non-depressed patients, 6 months following 
CABG they achieve substantial benefit to a level comparable to non-depressed patients. 
Baseline C!OL IImitation from angina and improvement following CABG are also similar in 
both groups. 
Rates of Medical Therapy Among Subset of Patlents post-CABG (N=255). 
Aspirin 
Prior MI or Stable Angina 
Anti-Lipids 
Prior MI 
Beta-Blockers 
Prior MI, CHF or Hypertensron 
Neither 
Calcium Antagonists 
Stable Angina 
No Stable Angina 
ACE inhibitors 
Prior MI 
CHF 
Diabetes 
Discharge (%) l&months (96) 
89 
55 
75 67 
64 56 
16 
19 
39 47 
56 66 
44 49 
ORAL CONTRIBUTIONS 
88 
81 
24 
19 
810 Understanding Risk Among Patients With 
Acute Coronary Disease 
Monday, March 31, 2003, 9:15 a.m.-lo:30 a.m. 
McCormick Place, Room S104 
9:15 a.m. 
81 o-1 Neovascularization Is the Most Powerful Independent 
Predictor for Progression to Disruption in High-Risk 
Atherosclerotic Plaques 
K-Raman Purushothaman, Valentin Fuster, William N. O’Connor, Pedro R. Moreno. 
University of Kentucky, Lexington, KY 
Background: High-risk lesions AHA type IV-Va may progress to disruptlon or regress to 
fibro-calcific lesions AHA Vb-Vc. Inflammation, fibrous cap thickness (FCT) and lipid area 
are critical determinants of progression. Furthermore. neovessels (NV) nourish the 
plaque and may play a role in plaque instability. This study quantified inflammation, FCT, 
liptd area. and plaque NV in high-risk, fibro-calcific and disrupted plaques. and compared 
their statistical power to predict plaque disruption. 
Methods: Studies were performed on 262 human autopsy aortic plaques. Plaque Inflam- 
mation, defined as >25 round mononuclear cells per high power field was quantified by 
light mwoscopy. Lipid area, defined by needle-shaped cholesterol cl&s was quantified 
by computerized planimetry FCT was quantified by ocular micrometry. NV, defined as 
tubuloluminal CD-34 positive capillanes were quantified wthw the fibrous cap and at the 
base of the plaque by manual counting on immunostained SectIons. 
Results: Inflammation. lipid area and NV content were increased in high-risk and dis- 
rupted plaques (Table). NV at the base of the plaque provided the strongest independent 
predictor f r plaque disruption (Table). 
Conclusion: High-risk and disrupted plaques have increased NV in comparison to fibro- 
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calcific plaques. In addition, NV was the most powerful independent predictor for disrup- 
tion, suggesting a cause-effect relationship between NV and progression to disruption in 
high-risk atherosclerotic plaques. 
prognostic role of cTnT and cTnl in patients with ACS or UA by means of a meta-analy- 
sis. 
High-Risk Disrupted Fibro-Calcific P 
(n=144) (Il=73) (n=45) valu 
e 
Methods: 45 studies from 1990 to 2000 were independently reviewed by 2 investigators; 
20 studies met the prespecified eligibility criteria. Odd ratio (OR) values were calculated 
for short-term (30 days) and long-term (25 months) outcomes in ACS patients, as well as 
In the subgroup of patients with UA. The primary outcome measure was the composite of 
death or nonfatal myccardial infarction. 
Plaque Inflammation (n) (%I 100 [69] 62 [ES] 10 [22] 0.00 
01 
Fibrous Cap Thickness (w) 273+246 34+16 414*317 0.00 
01 
Llpid Core Area (mm? 3.5 * 3.4 6.5 f 3.8 1.9+2 0.00 
01 
Neovessels at the Fibrous Cap a*17 7* 14 0.7+ 0.5 0.01 
(total number) 
Neovessels at the Base of the 29* 13 55+15 22*10 0.00 
Plaque (total number) 01 
Results: A total of 7,443 patients were included; 4,909 patients wereevaluated with a 
cTnT test and 2,534 with a cTnl test. Predictive values of cTnT and cTnl differed mini- 
mally according to a studied population and the follow-up period (Table). 
Conclusions: In patients with ACS, cTnT and cTnl elevation predicted similar odds of 
death or nonfatal myccardial infarction for both short- and long-term follow-up. In the sub- 
group of pabents with UA. cTnT or cTnl elevation predicted higher relative risk of short- 
term events when compared to the ACS cohort. 
Risk of Adverse Card,ac Events Carncd by Troponin Elevation 
Multiple Stepwise Logistic Regression Analysis to Predict Plaque Disruption 
Population 
ACS (short-term) 
Positive cTnT Positive cTnl 
Odds Ratio 95% Cl Odds Ratio 95% Cl 
4.76 3.48-6.53 3.70 2.50-5.46 
Predictor Relative 95% Confidence P 
Risk (RR) Intervals (Cl) ValU 
e 
Plaque Inflammation 
Lipid Core Area 
Fibrous Cap Thickness 
0.3 0.03 - 2.4 0.25 
1.13 0.96 1.3 0.15 
0.94 0.89 - 0.97 0.00 
1 
ACS (long-term) 
UA (short-term) 
UA (long-term) 
2.26 
7.30 
2.42 
1.71-2.99 3.99 1.57-10.14 
5.03-10.60 5.87 3X8-9.36 
1.76-3.31 3.99 1.57-10.14 
lo:oo a.m. 
810-4 
Neovessels at the Base of the Plaque 1.25 1.14 - 1.36 0.00 
01 
A Combination of Pro-BNP Och Troponin Tat Baseline 
Provide the Best Prediction of Risk of Death and 
Myocardial Infarction Early After Acute Coronary 
Syndrome 
9:30 a.m. 
810-2 The Eminently Preventable Pattern of Coronary Heart 
Disease: Focus on the Four Conventional Risk Factors 
Stefan James, Paul W. Armstrong, RobeR M. Califf. Per Venge, Maarten Simoons, Lars 
Wallentin, University Hospital, Uppsala, Sweden 
Umesh N. Khot Monica B. Khot, Christopher T. Bajzer, Shelly Sapp, E. Magnus Ohman, 
Sorin J. Brener, Stephen G. Ellis, Eric J. Topol, The Cleveland Clinic Foundation, 
Cleveland, OH 
Background: It is commonly believed that nwre than 50% of patients with coronary 
heart disease [CHD] lack any of the conventional risk factors [RF] (cigarette smoking, 
diabetes, hyperlipidemia, hypertension). This implies that other factors play a significant 
role in CHD and has led to interest in non-traditional RF and genetic causes of CHD. We 
tested the accuracy of this contention. Methods: We compiled data from 14 clinical trials 
Involving 122,458 patients with a wide spectrum of CHD. The prevalence of each con- 
ventional RF was calculated and patients were categorized according to their number of 
RF. Results: Patients without any of the four conventional RF constituted 15.4% of 
women and 19.4% of men. In men ~55 years and women ~65 years and most patients 
presenting with either unstable angina or for percutaneous Intervention, the prevalence 
of the conventional RF was even higher, with only IO-15% of patients lacking any of the 
four conventional RF. This pattern was Independent of gender, geographic region, and 
trial entry criteria. Premature CHD was related to cigarette smoking In both genders and 
diabetes I” women. Conclusions: In direct contrast with conventional thinking, 80.90% 
of patients with CHD have conventional RF. Although research into nontraditional RF 
and genetic causes of CHD is important, clinical medicine, public health policies, and 
research efforts should place significant emphasis on the four conventional RF and the 
lifestyle behawors that cause them to reduce the epidemic of CHD. 
Background: Elevated levels of Troponln T (TnT) and Brain Natriuretic peptide (BNP) in 
the acute stage acute coronary syndromes (ACS) has individually been shown to associ- 
ated with an increased risk of subsequent clinical events. 
Methods: The GUSTO IV ACS trial, evaluating the efficacy of abciximab as the primary 
medical treatment in ACS without early revascularization, included 7800 patients with 
chest pain withln 24 hours and elther ST-segment depression or elevation of troponin at 
entry. Levels of TnT and pro-BNP in blood samples obtained at randomization were ana- 
lyzed in 7115 and 6083 patients respectively. The results were related to clinical events 
at 30.days follow-up. 
Results: 
Troponin T Terbles of pro-BNP (ng/L) P (Chi? 
Prevalence of Patients Lacking Conventional Risk Factors by Age 
Age 545 46. 56. 66. ,75 
55 65 75 
N 1215 2624 3452 3450 1504 
4 0 4 0 0 
<317 317-1201 >I201 
Death (%) <= o.l”g/L 0.7 2.1 6.3 <O.OOl 
> O.iug/L 1.1 2.3 9.6 <0.001 
Death/ Ml (%) <= 0.1 ug/L 3.1 6.6 10.3 <0.001 
> o.l”g/L 5.3’ 7.6 14.5’ <0.001 
~~0.05 Ch? TnT > 0.1 as compared to <= O.l”glL 
In a multiple logistic regression analysis Including a large number of known clinical risk 
factors, TnT and pro-BNP were significant independent predictors of 30.day mortality 
and the combined endpoint. 
Conclusion: In a large cohort of patients with suspected ACS without ST-elevation lev- 
els of TnT and and pro-BNP provided independent prognostic Information. The combina- 
tlon of the markers provided an even stronger prediction of cllnical events in the early 
phase, 
IO:15 a.m. 
% Lacking Conventional Risk 11.1 129 16.8 21.4 29.6 pcO.001 for 
Factors trend 
9:45 a.m. 
810-3 Prognostic Role of Troponin T and Troponin I in 
Patients With Acute Coronary Syndromes: Meta- 
Analysis of 20 Studies 
81 o-5 A Robust Prediction Model for All Forms of Acute 
Coronary Syndromes: Estimating the Risk of In- 
Hospital Death and Myocardial Infarction in the Global 
Registry of Acute Coronary Events Registry 
Dmltriv N. Feldman, Michael Farkouh, Roxana Mehran. Eve D. Aymong, Martin Fahy, 
Eugenia Nikolsky, Andrea S. Abizaid, Alexandre A. Abizaid, George Dangas, New York- 
Weill Cornell Medical Center, New York, NY, Cardiovascular Research Foundation, 
Lenox Hill Heart and Vascular Institute, New York, NY 
Background: An elevation of cardiac troponin T (cTnT) or troponin I (cTnl) is predictive 
of adverse outcomes in patients with non-ST elevation acute coronary syndromes (ACS), 
defined as unstable angma (UA) or non-Q-wave myocardial infarction. However, differ- 
ences in the predictive value between cTnT and cTnl may exist. We Investigated the 
Kim A. Eaale Michael J. Lim, Andrzej Bud& Omar H. Dabbous. Karen Pieper, Shaun G 
Goodman, Christopher B. Granger, Philippe Gabriel Steg, Joel M. Gore, Keith A. Fox, on 
behalf of the GRACE Investigators. University of Michigan Health System, Ann Arbor. MI, 
The University and The Royal Infirmary of Edinburgh, Edinburgh, United Kingdom 
Background: Risk prediction models have been developed to assist clirwians in esti- 
mating risk of untoward outcomes in patients wth unstable angina (UA), non-ST seg- 
ment deviation myocardial infarction (NSTEMI), or ST segment elevation myocardial 
infarction (STEMI). We previously have devoloped a model for mortality prediction in 
patients with acute coronary syndromes (ACS). However, no single model exists that can 
predict risk of death or recurrent Ml (rMI) in all pabents presenting with (ACS). 
Methods: Using the GRACE database, we developed a multivariate logisbc regression 
model to predict the combined endpoint of death or rMI !n 18116 patients (2300 patients 
